Tower Research Capital (TRC)’s TNL Mediagene TNMG Stock Holding History

Tower Research Capital (TRC)’s Portfolio TNMG Stock Details TNMG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-50	Closed	-$136	–	5681
2025 Q4	$136	Buy	+50	New	+$292	﹤0.01%	5020
2025 Q1	–	Sell	-1	Closed	-$87	–	5964
2024 Q4	$87	Buy	+1	New	+$192	﹤0.01%	5484

Other funds holding TNMG

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Tower Research Capital (TRC)'s TNMG Position: Q1 2026 in Review

Tower Research Capital (TRC) sold out of TNL Mediagene (TNMG) in Q1 2026, closing a stake of 50 shares — an estimated $136 sold.

Tower Research Capital (TRC) first reported a position in TNMG in Q4 2024 and held it in 2 quarters. The position peaked at $136 in Q4 2025. 1 fund tracked by Wall St. Rank holds TNMG as of Q1 2026.

Tower Research Capital (TRC) reported no remaining TNL Mediagene position as of Q1 2026 after selling out during the quarter.
Tower Research Capital (TRC) sold 50 TNL Mediagene shares in Q1 2026, an estimated $136.
Tower Research Capital (TRC) first reported a position in TNL Mediagene in Q4 2024 and held it in 2 quarters.
Tower Research Capital (TRC)'s TNL Mediagene position peaked at $136 in Q4 2025.
1 fund tracked by Wall St. Rank held TNL Mediagene as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.